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Abstract
Arterial stiffness is considered both a risk factor and indicator of cardiovascular
disease. The purpose of this study was to examine the associations of cardiovascular risk
indicators of arterial compliance among 226 black and white individuals enrolled in an
outpatient clinical setting. Data were collected by survey and examination with a
computerized arterial pulse waveform analyzer. Arterial stiffness was estimated by
indirect estimates of small artery and large artery compliance, as well as pulse pressure.
After adjustments for age, race, and gender, logistic regression identified hypertension,
end organ damage, and ovenveight as the strongest predictors for the three arterial
stiffness indices. The results of this study identified similar factors associated with each
of the different noninvasive measures of arterial stiffness.

Keywords: arterial compliance, pulse pressure, cardiovascular disease

Abbreviations:
CVD - Cardiovascular Disease
C 1 - Large arterial elasticity
C2 - Small arterial elasticity
HDI - Hypertension Diagnostics, Inc
LAEI - large artery elasticity index
SAEI - small artery elasticity index
PP - pulse pressure
BP - blood pressure
BMI - body mass index
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One of the leading causes of mortality and a significant risk factor for
Cardiovascular Disease (CVD) is the progression of atherosclerosis. Atherosclerosis
includes the degenerative hardening of the arteries due to cholesterol-laden plaque
accumulation narrowing the arterial wall, causing loss of elasticity. The loss of arterial
elasticity and enhanced wave reflection are considered to be both markers of and an
independent risk factor of CVD, suggesting a focus on arterial wall health in the
prevention and treatment of this disease (Cohn J, 2001; Southerland et al. 2000; Van
Doormnum et al. 2003). The transformation in arterial wall elasticity can be monitored
and may help identify at risk patients and improve therapeutic decision making, due to
slow progressive changes in the viscoelastic properties of the arterial wall long before the
onset of disease symptoms (London G and Cohn J, 2002; Taal et aL 2007).
Arterial compliance is a measure of the storage capability of the blQod vesseL
Presently there is no "gold standard" to measure vessel compliance; most of the methods
used in previous years have been invasive techniques, which are not ideal in the clinical
setting. A developing and novel approach is the assessment of arterial pressure
waveform, a technique based on noninvasive measurements of pulse contour analysis
which allows the estimation of arterial elasticity and flexibility (Resnick et aL 2000).
A more traditional indirect measurement of arterial stiffuess is the pulse pressure

width, which is thought to be a cardiovascular risk factor in itself (Alderman et al. 1998;
Arnett et al. 1994). Pulse pressure is the difference between the systolic and diastolic
blood pressures, and is dependent on cardiac output, large arterial elasticity, and wave
reflection (Nichols W, 2005; Syeda et al. 2003). Wide pulse pressures are markers of
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increased vascular stiffness due to the loss of elastic recoil mechanism in the aorta; often
occurring linearly with age (Burt et al. 1995).
Arterial stiffness is a predictor of cardiovascular events independent of traditional
risk factors such as hypertension, diabetes, hypercholesterolemia, and stroke (Roman et
al. 2005). The associations of arterial stiffness and disease outcome may be due to both a
clinical and biological mechanism. However, it is unclear if disease progression can be
attributed to the estimates determined from these non-invasive measures.. This study
includes measurements of small and large arterial stiffness as well as a traditional
measure of pulse pressure in individuals with varying degrees of di~ease of end organ
disease.
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Historical Overview
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in
the US, affecting more than 80 million Americans each year, and costs this country
approximately $350 billion per year (AHA). One of the main risk factors for CVD is the
progression of atherosclerosis (Elter, JR, et aI., 2006). Atherosclerosis is the
degenerative hardening of the arteries due to cholesterol-laden plaque accumulation,
narrowing the arterial wall, causing loss of elasticity. Inflammation is a key component

of atherosclerosis and vascular endothelial cell damage due to the production of
circulating cytokines (Van DoomuID, et ai, 2003). Atherosclerosis is a slow progressive
disease that does not have immediate symptoms and thus many at risk individuals are
unaware of their disease state. Often the first indicator of this disease is a fatal acute
myocardial infarction (Naghavi et aI, 2006).
The arterial wall consists of three layers: the intima, media, and adventitia. The
intima is the inter-most surface of the arterial wall and is comprised mainly of endothelial
cells, which nonnally resist adhesion of monocytes. When the endothelial cells are
compromised they promote attachment of leukocytes due to the over expression of
adhesion molecules, such as Vascular adhesion molecule-l (VCAM-l), interleukin-l (ILl), and tumor necrosis factor-a (TNF- a); which binds leukocytes that are found in the
composition of plaque. This process is highly influential in the progression of
inflammation. These monocytes migrate through the intima and mature into
macrophages, which causes accumulation of cholesterol esters, forming foam cells
producing a fatty streak. The media is comprised of smooth muscle cells (SMC), elastin,
and collagen fibers, which are ultimately responsible for vessel constriction. Early stages
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of atherogenesis leads to the development of 'complex plaque' due to the migration of
SMC from the media to the intima, where fibro-lipid lesions are produced in the intima
forming fibrous cap and necrotic core. The outer-most layer, adventitia, is comprised of
fibrous connective tissue which maintains the vessel shape. Physical disruption of the
lesion causes thinning and fracturing of the fibrous cap causing plaque rupture which
leads to thrombus formation (Paquette et aI, 2000; Augst et al 2007; Hashimoto et al
1999; Beck et al 2005; Booth et aI, 2004).
Studies suggest that chronic inflammatory diseases and conditions may lead to an
increased procoagulant state in the peripheral blood; which suggests that the same
"systemic" markers associated with various vascular disease states may also be
associated with cardiovascular disease and causally with atherosclerosis, myocardial
infarction, stroke, and thrombosis (Loos, BG et ai, 2005). These similar parameters may
be involved with the atherosclerosis process in different organs throughout the body.
Therefore, we can attempt to conclude that these same markers found in the peripheral
blood may provide a biologically plausible explanation to the epidemiological link
between chronic blood diseases (Loos, BG, et ai, 2005). The loss of arterial elasticity
and enhanced wave reflection are not only thought to be markers ofCVD, but also an
independent risk factor for CVD, suggesting a focus on arterial wall health in the
prevention and treatment of CVD (Cohn IN et aI, 2001; Southerland JH, et ai, 2006).
The loss of arterial elasticity and enhanced wave reflection are due to the
pathophysiological changes in the blood vessel, affecting vascular endothelial function of
both the small and large arteries leading to a reduction in arterial compliance which is
known to be associated with numerous cardiovascular events (Glasser et al 1997). This
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transfonnation in arterial wall elasticity can be monitored and may help identifY at risk
patients and improve therapeutic decision making~ due to slow progressive changes in the
viscoelastic properties of the arterial wall long before the onset of disease symptoms
(Glasser et aI, 1997).
Vascular wall dynamics can be examined in a variety of ways. Arterial stiffness
refers to resistance in deformation of the vessel wall . Arterial compliance is a measure of
the storage capability of the blood vessel, and is defined as absolute change in volume,
diameter, and area per change in pressure. Another common assessment is arterial
distensibility which is the percent change in arterial compliance. Distensibility allows
one to compare vessels of different sizes. Lastly, arterial elasticity, based on elastic
modulus, describes the change in stress, or force per unit area, for a given change in
strain, the ratio of change in area to the initial area. This measurement is independent of
size and shape, and is used to assess vessel stiffness (Glasser et ai, 1997).
Presently there is no "gold standard" to measure arterial compliance. Most of the
methods used in previous years have been invasive techniques, which are not ideal in the
clinical setting. There are three suggested mechanism to measure both large and small
arterial compliance; which include last systolic pressure augmentation, biopsy of an
isolate section of the small artery, and recently and most importantly assessing the arterial
pressure wavefonll. This technique is based on a noninvasive measurement of pulse
contour analysis which allows estimation of arterial elasticity and flexibility (Resnick et
al 2000; Finkelstein et ai, 1988).
The HDIlPulsewave CR-2000 Research Cardio Vascular Profiling System,
(Hypertension Diagnostics, Inc, Eagan, Minnesota., USA, 2001) can be used to evaluate
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arterial compliance through a computerized arterial pulse waveform analysis, that
calculates the diastolic decay of the pulse wave, which allows for inferences of
vasculature resistance along with stroke volume ejection and systemic vascular resistance
in the arterioles (Syeda et aI, 2003; Nichols, 2005). This user friendly device computes
arterial compliance by measuring response voltage from applied mechanical stress and/or
strain over an electric field over the radial artery. The best possible explanation of
waveform analysis is based on the modified Windkessel model in electrical terms
(Glasser et al. 1997) (Figure 1). This model has two main parallel components, a resistor
and a capacitor, representing the small and large arterial compliance, which is connected
to a voltage source. This voltage source represents the left ventricle of the heart, which
conducts blood flow into the system during systole creating proximal arterial pressure in
the large vessels. This pressure is considered the pulsatile flow which defines the
forward and reflecting waves due to stroke volume ejection into the aorta which is
dependent on the compliance of the artery. This computerized method uses the arterial
pressure to estimate capacitive compliance in the aorta, which represents the central
determinant of systemic arterial compliance (SAC), C 1, and is therefore a marker for
large arterial stiffness. The interance element represents the inertia of the blood to the
smaller blood vessels, where the oscillatory compliance is measured representing the
distal pressure of the continuous, steady state flow across the small arteries. The brachial
artery is the detennjnant of the peripheral arterial compliance (PAC), C2, and therefore is
a marker for small artery elasticity (SAE). These measurements are collectively
considered the diastolic decay of the pulse wave, which allow for inferences of
vasculature resistance along with stroke volume ejection and systemic vascular resistance
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(SVR) in the arterioles (Cohn et aI, 2001; Glasser et al~ 1997; Syeda et ai, 2003; Nichols~
2005).
A more traditional indirect measurement of arterial stiffness is the pulse pressure
width, which is thought to be a cardiovascular risk factor in itself.. Pulse pressure is the
difference between the systolic and diastolic blood pressure, and is dependent on cardiac
output, large arterial elasticity, and wave reflection. Arterial stiffness due to structural
changes in the arterial walls causes an increase in pulse wave velocity, and thus an
increase in pulse pressure (Roman, MJ et af., 2005) . This increase in pulse pressure is
due to the decrease in diastolic blood pressure which leads to myocardial ischemia and
CVD. Systolic blood pressure increases linearly with age; however, diastolic blood
pressure increases until around the age of 55, and then begins to decrease. This is due in
part!, to the loss of compliance, leading to a widening of the pulse pressure. Systolic
hypertension and widen pulse pressure are markers of increased vascular stiffness due to
the loss of elastic recoil mechanism in the aorta. When this loss occurs, the full stroke
volume delivery through the resistance arterioles occurs during systole, instead of
through a smooth steady flow throughout diastole . This widening effect of pulse pressure
is a predictor of cardiovascular events (Burt et aI, 1995).
Reduction in arterial compliance leads to a disproportionate increase in systolic
blood pressure in the ascending aorta (Nichols, \\TN, 2005).. Decreased compliance has
two main adverse effects on central circulation: First the aorta stiffens and a blood
injection from the left ventricle generates a pressure wave. The amplitude of this pulse
pressure is higher in the aorta than in the left ventricle due to increased impedance.
Second, there is an increase in systolic pressure due to early wave reflection causing a
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decrease in diastolic blood pressure. (Rietzschel, ER et ai, 2001). Both the systolic and
pulse pressures become increased due to an alteration in the timing of reflected waves
(Roman, MJ et al., 2005). This ultimately causes an increase in arterial pressure wave
velocity which is an indicator of arterial stiffness (Vlachopoulous, C et ai, 2005).
Arterial stiffness is a predictor of cardiovascular events independent of traditional
risk factors such as hypertension, diabetes, hypercholesterolemia, and smoking (Roman,
MJ et ai., 2005). The relationship between atherosclerosis and inflammation is quite
evident according to the current literature, it was also suggested by Yasmin et al. that
elevated levels of inflammatory mediators may be strongly associated with arterial
stiffening. This study reported that C-reactive protein may be independently related to
higher pulse wave velocity and pulse pressure which are known surrogates of loss of
arterial elasticity (Yasmin, MCM, et al., 2004).
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Contemporary Related Studies
Current literature suggests both a clinical and biological causal mechanism may
exist to explain the potential association between chronic systemic diseases and
cardiovascular disease progression. However, current evidence is insufficient to support
the idea that systemic inflammation is an individual risk factor for cardiovascular disease.
It is important to study the interrelationship between end organ diseases due to the large
volume of people who are simultaneously, chronically affected by multiple inflammatory
diseases. Even a small association between disease states would be vital information for
the dental, diabetic, and especially the cardiovascular disease community_ There are
many phannacological and non-pharmacological therapies available to prevent and
reduce the severity of atherosclerosis and the events associated with CVD.
Some studies suggest that males have a higher burden of cardiovascular disease
events as well as a higher burden of other blood related diseases, such as periodontal
disease (Desvarieux, Met ai, 2004). Thus, it is important to examine gender differences,
along with possible race and/or ethnic differences when studying the relationship
between systemic diseases and atherosclerosis. When examining the Atherosclerosis
Risk In Communities (ARIC) study population, the investigators suggest that estrogen
may playa protective role against vessel stiffness in premenopausal women. When
compared to postmenopausal women, premenopausal women had less arterial stiffness,
even when compared to men of the same age range (Arnett et aI, 1994; Glasser et al
1997).. Benetos et al showed that women tend to have a 5-10% lower stiffness than men
of the same age.
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Atherosclerotic progression occurs with the aging process, but the rate is
accelerated with comorbid condition including high blood pressure, high cholesterol,
smoking, and diabetes. Nearly all studies measuring vascular stiffness and reduced
compliance have shown age as an intrinsic component of increase stiffness (Weinberger
et aI, 2002). Benetos et ai, demonstrated this in subjects over the age of 50, in which a
rapid increase in SBP and decrease in compliance was discovered, along with a plateau
effect of the DBP; which continually decreased with age. Additional studies showed that
with each decade increase in age, arterial stiffness increases by approximately 10-15%
after the age of lOin both males and females (Benetos et ai, 2002).
Hypertensive individuals have stiffer, less compliant arteries than normotensive
individuals (Beck, JD et ai, 2005). The adverse effect of hypertension results in
ventricular hypertrophy of the medial layer. In younger hypertensive patients, elevated
BP does not affect the vasculature width in the radial artery, however, in central arteries
the width increases propo~ionately with BP levels. In elderly hypertensive populations,
arterial stiffening is primarily due to the development of plaque in the arteries
independent ofBP levels. Even in elderly hypertensives, vessel width only changes in
the central arteries. In the Hypertension Detection and Follow-up Program, Alderman et
al found elevated relative risk of 5-yr mortality with DBP, SBP, and pulse pressure in this

hypertensive population. Even after adjusting for additional covariates, pulse pressure
was found to be a significant predictor of overall mortality and is considered an
independent predictor of cardiovascular disease events. (London et ai, 2002). The
Framingham study also depicted pulse pressure as a strong predictor of CVD more
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specifically of myocardial infarction in both hypertensives and normotensives (Benetos et

al, 1997; Benetos et aI, 1998).
Fasting glucose is also known to be highly associated with arterial stiffness,
proportionately with level of blood glucose, even among normal healthy subjects.
Hyperglycemia is a common factor for both Type 1 and Type 2 diabetic individuals, and
has been shown to be associated with an increase in arterial stiffness when compared to
non-diabetic individuals, even though many other factors including disease duration and
degree of therapy control are thought to influence this affect as well.

In vitro studies have shown a link between arterial stiffness and
hypercholesterolemia along with clinical studies suggesting a significant positive
correlation between cholesterol and low-density lipoprotein cholesterol (LDL), and a
negative correlation with high-density lipoprotein cholesterol (HDL) with arterial
stiffness. Familial hypercholesterolemia has also been shown to be associated with the
stiffening of the arterial wall; which implies possible genetic and environmental
components may play an essential role in the development of arterial stiffness and
atherosclerosis.
Additional studies have shown impaired arterial flexibility especially in the aortic,
carotid., iliac, and brachial arteries in patients with congestive heart failure (CHF).
Arterial stiffness has been shown to be causally related to increase of SBP and pulse
pressure in patients with End-stage Renal Disease (ESRD) and is an independent risk
factor for CVD related morbidity and mortality (Benetos et aI, 2002).
Cigarette smoking is another known risk factor for atherosclerosis accelerating
endothelial damage., possibly due to inhibited basal and nitric oxide (NO) production.
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Cigarette smoking elevates blood pressure levels even at an acute level, and has been
shown to decrease arterial compliance in both normotensives and hypertensive smokers
compared to non-smokers.
Exercise has been shown to be associated with arterial compliance, but only in a
few studies; in which they illustrated exercise training caused an increase in arterial
compliance contributed to enhanced maximal oxygen consumption (Glasser et aI, 1997).
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Significance

The relationship of atherosclerosis and "systemic" disease is unclear particularly
among whites and blacks. This study implements a novel measurement of arterial
stiffness as well as a traditional measure of pulse pressure in a dental health population
with individuals with varying degrees of disease of different organs throughout the body.
The results can be used to identify common factors in the mechanism of atherosclerosis
as well the results will identify dental, diabetic, endocrine, and hypertension professionals
as an important component of cardiovascular disease prevention. This study will assign
the risks of multiple indicators of arterial stiffness with hypertension,
hypercholesterolemia, end organ damage, and overweight in black and white men and
women. Early detection of atherosclerotic markers in high risk individuals may prove to
be opportunistic in identifying cardiovascular events that may also be progressing along
with other comorbid diseases (Morrison et ai, 1995).
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Figure 1. Electrical schematic of the modified Windkessel model of the vasculature.
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Abstract
Arterial stiffness is considered both a risk factor and indicator of cardiovascular
disease. The purpose of this study was to examine the associations of cardiovascular risk
indicators of arterial compliance among 226 black and white individuals enrolled in an
outpatient clinical setting. Data were collected by survey and examination with a
computerized arterial pulse wavefonn analyzer. Arterial stiffness was estimated by
indirect estimates of small artery and large artery compliance, as well as pulse pressure.
After adjustments for age, race, and gender, logistic regression identified hypertension,

end organ damage, and overweight as the strongest predictors for the three arterial
stiffness indices. The results of this study identified similar factors associated with each
of the different noninvasive measures of arterial stiffuess.

Keywords: arterial compliance, pulse pressure, cardiovascular disease

Abbreviations:
CVD - Cardiovascular Disease
C 1 - Large arterial elasticity
C2 - Small arterial elasticity
HDI - Hypertension Diagnostics, Inc
LAEI - large artery elasticity index
SAEI - small artery elasticity index
PP - pulse pressure
BP - blood pressure
BMI - body mass index
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Introduction
One of the leading causes of mortality and a significant risk factor for
Cardiovascular Disease (CVD) is the progression of atherosclerosis. Atherosclerosis
includes the degenerative hardening of the arteries due to cholesterol-laden plaque
accumulation narrowing the arterial wall, causing loss of elasticity. The loss of arterial
elasticity and enhanced wave reflection are considered to be both markers of and an
independent risk factor of CVD, suggesting a focus on arterial wall health in the
prevention and treatment of this disease [Cohn J, 2001; Southerland et a1. 2000; Van
Doonnnum et al. 2003]. The transformation in arterial wall elasticity can be monitored
and may help identify at risk patients and improve therapeutic decision making, due to
slow progressive changes in the viscoelastic properties of the arterial wall long before the
onset of disease symptoms [London G and Cohn J, 2002; Taal et a1. 2007].
Arterial compliance is a measure of the storage capability of the blood vessel.
Presently there is no 4'gold standard" to measure vessel compliance; most of the methods
used in previous years have been invasive techniques, which are not ideal in the clinical
setting. A developing and novel approach is the assessment of arterial pressure
waveform, a technique based on noninvasive measurements of pulse contour analysis
which allows the estimation of arterial elasticity and flexibility [Resnick et al.. 2000].
A more traditional indirect measurement of arterial stiffness is the pulse pressure
width, which is thought to be a cardiovascular risk factor in itself[Aldennan et al. 1998;
Arnett et al. 1994]. Pulse pressure is the difference between the systolic and diastolic
blood pressures, and is dependent on cardiac output, large arterial elasticity, and wave
reflection [Nichols W, 2005; Syeda et a1. 2003]. Wide pulse pressures are markers of
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increased vascular stiffness due to the loss of elastic recoil mechanism in the aorta; often
occurring linearly with age [Burt et aL 1995].
Arterial stiffuess is a predictor of cardiovascular events independent of traditional
risk factors such as hypertension,

diabetes~

hypercholesterolemia, and stroke [Roman et

a1. 2005]. The associations of arterial stiffness and disease outcome may be due to both a
clinical and biological mechanism" However, it is unclear if disease progression can be
attributed to the estimates determined from these non-invasive measures. This study
includes measurements of small and large arterial stiffness as well as a traditional
measure of pulse pressure in individuals with varying degrees of disease of end organ
disease.

Methods
Study Population
This study is a cross-sectional assessment of 226 subjects from a dental health
clinic at the Medical University of South Carolina, as well as a local independent
retirement community. All data were previously collected infonnation from health
surveys and pulse contour analysis" The 33 question self-report survey was conducted by
an interviewer which included demographic information, socioeconomic status
infonnation, and medical history.
Measurements of Arterial Compliance
This study includes three measurements that estimate arterial stiffness in black
and white men and women "",jth varying degrees of CVD related risk factors, including
hypertension, hypercholesterolemia, and body mass index (BMI).. The HDIlPulsewave
CR. . 2000 Research Cardio Vascular Profiling System, (Hypertension Diagnostics, Inc,
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Eagan, Minnesota, USA, 2001) was used to evaluate arterial compliance through a
computerized arterial pulse waveform analysis, that calculates the diastolic decay of the
pulse wave, which allows for inferences of vasculature resistance [Finkelstein et al. 1991;
Zimlichman et al. 2005]. Arterial compliance is defined as absolute change in volume,
diameter, and area per change in pressure. This computerized model uses arterial
pressure to estimate capacitive compliance in the

aort~

which represents the central

determinant of systemic arterial compliance, C 1; and is therefore a marker for large
arterial stiffness (LAEI). Oscillatory compliance is measured in the brachial artery, the
detenninant of the peripheral arterial

compliance~

C2; and is thus a marker for small

artery stiffness (SAEI). The best possible explanation of wavefonn analysis is based on
the modified Windkessel model [Glasser et aL 1997].
Cardiovascular profile measurements were taken with the subject in supine
position from the upper right ann by a blood pressure cuff and left radial artery by a pulse
pressure sensor.
Large Arterial Elasticity Index (LAEI), Small Arterial Elasticity Index (SAEI},
and Pulse Pressure (PP) were used to compare those with and without cardiovascular
related risk factors, including hypertension, hypercholesterolemia, end organ damage,
and being overweight. The distribution of the data was examined and subjects were
considered to be 'high risk' for reduced arterial compliance if they were included in any
of the three upper quartiles ofLAEI, SAEI, or PP. An Arterial Stiffuess Score of 0-3 was
assigned to each subject based on the number of upper quartiles in which the subjects
were stratified.
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Subjects were considered to have end organ damage if they had a history of
diabetes, stroke, heart disease, myocardial infarction, kidney disease, or lung or leg vein
blood clots.
Cardiovascular disease risk was also detennined from systolic BP, diastolic BP,
body mass index (BMI), pulse pressure (PP), and mean arterial blood pressure.
Data Management and Statistical Analysis

Data are reported as frequencies for categorical variables and means ± standard
deviation for continuous variables. Pearson's Correlations were used for continuous
variables and Chi-squared proportions were used for categorical variables to compare risk
factors and hemodynamic parameters. Multivariable cross-sectional modeling using
binary logistic regression was used to estimate odds ratios and 95% confidence intervals
for CVD outcomes by Arterial Stiffness Score categories. Statistical analyses were
conducted using SAS analysis software, and were considered statistically significant at
the .05 level.

Results
Compliance Measurements

Assessments were completed on 226 dental clinic subjects. The compliance
parameters in relation to risk factors and demographic characteristics of the subjects are
provided in Table 1. The mean Large Arterial Elasticity Index (LAEI) was 13.4 ± 5.35
mL/mmHg x 10, mean Small Arterial Elasticity Index (SAEI) was 4.9 ± 3.9 mL/mmHg x

100, mean pulse pressure (PP) was 60.8 ±

25.9~

and the mean age was 60.5 ± 15.6 in the

total study cohort. No differences in LAEI, SAEI, or PP were detected between white
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and black subjects, between subjects with and without hypercholesterolemia, or between
smokers and non-smokers (Table 1).
Female subjects had significantly greater reductions in both LAEI (p <.0001) and
SAEI (p = .002) but no difference in PP when compared to male subjects. Subjects with
BMI greater than 25 were found to have significantly reduced LAEI (p
subjects with end organ damage had significantly reduced LAEI (p

~

=

.004). Whereas

.01) and SAEI (p

=

.007) (Table 1).
Patients older than 60 years of age showed a significant reduction in LAEI (p
<.0001), SAEI (p <.0001), and PP (p = .02). It is known that the arterial elastic recoil
function is reduced significantly after the age of 60 and thus we would expect to see a
reduction in the small and large arterial compliance as well as with pulse pressure
measurements due to this age-related physiological change in vessel function [Izzo J and
Black H, 1999]. Subjects with hypertension also showed a significant reduction in LAE
(p <.0001) and SAE (p <.0001), and a slight reduction in PP (p = .09) when compared to

subjects without hypertension (Table 1).
LAEI and SAEI compliance parameters were highly statistically correlated (p
<.0001) with a Pearson's correlation coefficient 0[0.358 (-0.095, 0.164). This was to be
expected because both the small and larger arterial elasticity indices were measured using
the same mechanism on two different vessels. The LAEI and PP parameters were
inversely correlated (p = 0.04) with a Person's coefficient of - 0.141 (-0.266, -0.011). As
the large arteries become more rigid the pulse pressure increases, resulting in an inverse
relationship between these two parameters. However, the SAEI and PP parameters were
not significantly correlated.
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Each of the 226 participants was assigned an arterial stiffness score based on
placement in upper quartiles of the three arterial stiffness indices. Over half (57 . 5%) of
the participants had a score of 0 (Table 2). The prevalence decreased with each score
category, 22.1 % with a score of 1, 11.1 % with a score of 2 and 9.3% with a score of 3
(Table 2).
Associations with Level of Vessel Disease
(Arterial Stiffness Score)
Table 3 presents the association of age, gender, race, and arterial stiffness score
with hypertension, hypercholesterolemia, end organ damage, and overweight. Age was
significantly associated with hypertension, hypercholesterolemia, and end organ damage
with greatest risk in age greater than or equal to 60 years. Males and blacks were
significantly more likely to be overweight than their female and white counterparts"
Hypertension and end organ damage increased significantly with arterial stiffuess score.
The crude and adjusted odds ratios for hypertension~ hypercholesterolemia, end
organ damage, and overweight by arterial stiffness score are presented in table 4. No
significant patterns were detected by the adjusted model. However, significant odds
ratios were identified for hypertension and end organ damage for arterial stiffness score
of2.

Discussion
This cross-sectional study compared three indicators of vascular compliance
estimated from non-invasive measurements with the calculations of a risk score based on
the upper quartile in the three measures. Over half of the subjects had a score of 0, with
42.5% having a score of 1 or greater. While the majority of the study population was
over 60 years of age and had one or more cardiovascular disease risk factors and end
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organ damage, less than 10% had a score of 3. When comparing SAEI, LAEI, and PP as
continuous measures, SAEI and LAEI were found to be significantly correlated with each
other. This would be expected as both measures were estimated from the same pulse
wave analysis. However, PP, also estimated from the same measurement was not
associated with either SAEI or LAEI.
The analyses in this study identified similar factors associated with the three
indicators of arterial stiffness. Age and hypertension were significantly associated with
the highest risk measurements with each of the three. End organ damage and gender
were associated with SAEI and LAEI but not with PP. The higher rates of stiffer arteries
among women are consistent with other studies in that women tend to have a 5-10%
lower stiffness than men of the same age [Benetos et al. 2002].
Atherosclerotic progression occurs with the aging process, but the rate is
accelerated with comorbid conditions. Nearly all studies measuring vascular stiffness
and reduced compliance have shown age as an intrinsic component of increase stiffness
[Weinberger et al. 2002]. Benetos et al demonstrated with each decade increase in age,
arterial stiffness increases by approximately 10-15% after the age of lOin both males and
females [Benetos et al. 2002]. We found significant associations between advanced
vessel disease and age, especially among subjects greater than 60 years of age.
Hypertensive individuals have stiffer, less compliant arteries than normotensive
individuals [Beck J and Offenbacher S, 2005; Benetos et al. 1997; Benetos et al. 1998].
In elderly hypertensive populations, arterial stiffening is primarily due to the loss of
elastic recoil function in the arteries. In this study we found hypertension, end organ
damage, and being overweight to be associated with arterial compliance estimates and
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with Arterial Stiffness Score. After adjusting for age, sex and race, significant odds

ratios for hypertension and end organ damage were only detected for individuals with a
score of2.
There are several limitations in this study. First, the information collected was
from a self-report interviewer survey, which may have biased some of the parameters
recorded, such as smoking status and diabetes.. In addition, the drug and treatment
infonnation collected in this study was not complete or reliable.
The three indicator assessed arterial stiffness differently and at different parts of
the body_ One might expect different values given disease progression may be different.
For example, disease progression and arterial compliance might be different in the small
arteries as opposed to the large arteries and pulse pressure.. Thus, disease might be
detected earlier in the small arteries. However, these assessments did not detect such
differences.
Early detection of atherosclerotic markers in high risk individuals may prove to be
opportunistic in identifying cardiovascular events that may also be progressing along
with other comorbid diseases [Morrison et al. 1995].

Conclusions
The three different indicators of arterial compliance had similar factors associated
with the measurements. Likewise, the associations with disease outcomes were similar
for the three measures. The arterial stiffness score summing the highest risk group was
associated with the highest disease risk. These results identify one of the three
assessments of arterial stiffness are associated with increased disease risks. However!' the
analyses failed to identify anyone of the three measures as superior in predicating
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disease. As the three indicators were detennined from one measurement, each marker
should be correlated. Future longitudinal studies are needed to detennine if SAEI or
LAEI is an independent predictor of CVD. Such studies should include measures of
arterial stiffness prior to end-organ damage with follow-up.
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Table 1. Compliance parameters in relation to CVD risk factors (N = 226)
CVD Risk Factors
LAEI
SAEI
Age> 60 (n =119)
11.6 ± 5~1
3.5 ± 2.1
Age < 60 (n =107)
15.5 ± 4.9
6.4 ±4.8
P value
<.0001
<.0001
Men (n = 99)
15.6 ± 4.6
5.8 ± 3.6
Women (n = 127)
11.8 ± 5.3
4.1 ± 4.1
Pvalue
<.0001
0.002
White (n = 184)
13.4 ± 5.4
4.9 ± 4.1
Black (n = 41)
14.0 ± 5.0
4.7± 3.1
NS
Pvalue
NS
Hypertension (n = 107)
11.9 ± 5.2
3.8 ±2.4
Not Hypertensive (n = 119)
14.9 ± 5.1
5.8±4.7
P value
<.0001
<.0001
Hypercholesterolemia (n = 98)
13.3 ± 5.7
4.5 ±2.7
Not Hypercholesterolemia (n = 128)
13.6±5.1
5.1 ± 4.6
P value
NS
NS
End Organ Damage (n = 84)
12.3 ± 4.9
3.7 ± 2.1
Not End Organ Damage (n = 142)
14.1 ± 5.5
5.5 ±4.6
P value
.01
.007
BMI ~ 25 (n = 160)
14.1±5.5
4.9 ±3.0
BMI < 25 Cn = 66)
11.9 ± 4.6
4.8 ± 5.5
P value
0.004
NS
Smoker (0 = 9)
15.2 ± 4.0
5.9 ± 3.4
Non-smoker (n = 217)
13.4 ± 5.4
4.8±4.0
Pvalue
NS
NS

pp
64.7 ± 14.3
56.3 ± 34.0
0.02
61.7 ± 35.4
60.0 ± 14.8
NS
61.1 ± 27.8
58.4 ± 13.3

NS
63.8 ± 13.5
58.0 ± 33.1
0.09
61.9 ± 13.3
60.1 ± 32.4
NS
63.2 ± 14.7
59.3 ± 30.6
NS
61.6 ± 29.5
58.6 ± 13.4
NS
57.0 ± 6.7
60.9 ± 26.3
NS

SAEI- small arterial elasticity index (in mUmmHg x IOO)~ LAEI = large arterial elasticity index (in mUmmHg x 10);
pp;= pulse pressure mmHg; NS = not significant~ determined by Pearson's correlationp-value.

Table 2. Percentages of risk groups by Arterial Stiffness Score
Arterial Stiffness
Score

0
1
2

3

Upper Quartiles

None
LAE
SAE

Total Study
(N=226)
130
16
24

Total Study

10
13

4.4

pp
LAE*SAE
LAE*PP
SAE*PP
LAE*SAE*PP

LAE = large arterial elasticity index; SAE = small arterial
* = mUltiple upper quartHes.

6
6
21
elasticity~

%

57.5
7.0
10.6
5.8
2.7

2.7
9.3
PP = pulse pressure~
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Table 3. Distributions of CVD Outcomes by Arterial Stiffness Score, age, gender, and race. (N=226)

Model
Covariates

Total Study
226 (100 f.llo)

Hypertension
107 (47%)

CVD Outcomes
HyperEnd Organ
Damage
cholesterolemia
84 (37%)
98 (430/0)

Overweight
160 (71O/f.l)

Age

2:: 60
<60

119(53%)
107 (47%)
p-value

78 (66%)
29 (27%)
<0.0001

60 (50%)
38 (36%)
0.024

63 (53%)
21 (20%)
<0.0001

81 (68%)
79 (74%)

99 (44%)
127 (56%)

46 (47%)
61 (48%)

50(51%)
48 (38%)
0.056

38 (38%)
46 (360/0)
0.74

77 (78%)
83 (65%)
0.042

75(41%)
22 (54%)

71 (39%)
12 (29%)
0.26

121 (66%)
38 (93%)
0.0006

0.34

Gender
Male
Female

p-value

0.82

Race
White
Black

184 (81%)
41(18%)

p-value

83 (45%)
23 (56%)
0.20

0.13

Score
130 (58%)
50 (22%)
25(11%)
21 (90/0)

56 (43%)
46 (34%)
26 (52%)
21 (420/0)
20 (80%)
8 (32%)
2
13 (62%)
15(71%)
3
0.23
p-value
<0.0001
Score == Arterial Stiffuess Score; Overweight = BMI > 25; categorical variables
p-value determined by Chi-square.
0

1

36 (28%)
101 (78%)
32 (64%)
19 (38%)
15 (60%)
19 (76%)
10 (48%)
12 (57%)
<0.0001
0.0599
are presented as counts (row %);

Table 4. Odds Ratios and 95% Confidence Intervals for Cardiovascular
Disease (CVD) outcomes by Arterial Stiffness Score
Adjusted Model §
Crude Model
CVD Outcomes by
Arterial Stiffness Score
Odds Ratio (95% CI) Odds Ratio (95% CI)
Hypertension
1 1.98 (1.02, 3.83)
1.02 (0.47, 10.33)
3.25
(1.02, 5.83)
2 7.30 (2.57, 20.74)
1.88 (0.61, 1.10)
3 4.57 (1.66, 12.57)
1.0
0 1.0
Hypercho lestero lemia
0.64 (0.30, 1.37)
1 0.96 (0.49, 1.85)
0.36 (0.13, 1.03)
2 0.62 (0.25, 1.54)
1.36 (0.47, 3.94)
3 2.15 (0.83, 5.53)
1.0
1.0
0
End Organ Damage
1.09 (0.50, 2.36)
1 1.60 (0.80, 3.18)
4.92 (1.66, 14.59)
2 8.27 (3.06,22.36)
1.32 (0.46, 3.82)
3 2.37 (0.93, 6.07)
1.0
0 1.0
Overweight
0.47 (0.21, 1.05)
1 0.51 (0.25, 1.04)
0.44 (0.16, 1.25)
2 0.43 (0.18, 1.06)
0.38 (0.12, 1.15)
3 0.38 (0.15, 0.98)
0 1.0
1.0
Reference grQUp = score of zero; Overweight = BMI > 25: § Adjusted for Age, Gender, Race
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The three different indicators of arterial compliance had similar factors associated
with the measurements. Likewise, the associations with disease outcomes were similar
for the three measures. The arterial stiffness score summing the highest risk group was
associated with the highest disease risk. These results identify one of the three
assessments of arterial stiffness are associated with increased disease risks. However, the
analyses failed to identify anyone of the three measures as superior in predicating
disease. As the three indicators were determined from one measurement, each marker

should be correlated.
This study was a hypothesis driving study to assess cardiovascular disease risk
factors, especially hypertension and end organ damage in a local population cohort with
varying disease states. The results from this study suggest that this noninvasive screening
method could potentially be used in the clinical setting as an alternative diagnostic tool in

regards to cardiovascular health. Pulse contour analysis should be further studied in a
true clinical setting to examine the diagnostic and economical benefits of this noninvasive

screening method. Future longitudinal studies are needed to determine if SAEI or LAEI
is an independent predictor of CVD. This study allowed me to gain knowledge in
cardiovascular disease health, especially in hypertension. I plan to continue my
education in epidemiology with a focus in cardiovascular disease and hypertension
research.
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Appendix A - Preliminary Study Sample Size
With a sample size of 226, approximately 19 and 107 subjects per group are
needed for a two-sample, two-sided .10 significance level at a power of 80% with an
effect size of 0.600 to detect an approximate 3 ml/mmHg clinically important difference
(as reported in Woodman et al) in large arterial elasticity, Cl assuming a standard
deviation of5.0. Approximately 29 and 197 subjects per group are required for a twosample, two-sided 0.10 significance level at a power of 80% with an effect size of 0.500
to detect an approximate 2 ml/mmHg clinically important difference (as reported in
Woodman et al) in small arterial elasticity, C2 assuming a standard deviation of 4.0.
Refer to Table B for sample size calculations.

Table B: Two group t-test of equal means (unequal n's)
Test significance level, a
1 or 2 sided test?
Group 1 mean, m)
Group 2 meao, ml
Difference in means, m1 - m2
Common staodard deviation, s
Effect size, d = Imt - m21 / s
Power ( %)
D:z

Ratio: 02/ nl
N = 01 + 82

1

2

0.100

0.100

2

2

14.900
11.900
3.000
5.000
0.600
80
19
207
10.105

5.800
3.800
2.000
4.000
0.500
80
29
197
6.069

226

226
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Appendix B - Preliminary Studies
CDC Wonder was utilized to determine the mortality rate of hypertension based
in the state of South Carolina from 1999-2003. The lCD-iO code used to identify
hypertensive diseases were HIIO-HII3, which includes essential hypertensive diseases,
hypertensive heart disease, and hypertensive renal disease. Results were grouped by race.
All genders, ages, races, and urbanizations were included. Rates were standardized to the
2000 US population. Age Adjusted Rates and Crude Rates Per 100,000 for all of the
South Carolina counties, grouped by race (i.e. White, Other, Black or African American)
are shown in Table A. The counts of the disease by race are also shown in Table A.

Maps 1,2 and 3 display the same infonnation geographically, grouped by county. The
Age Adjusted Rates per 100,000 for Black or African American in South Carolina is
41.5, Whites is 13.1, and Other 1.7 (may be unreliable). The mortality rates of Blacks
(African American) due to hypertension related diseases are drastically higher in South
Carolina as compared to White and Other Races groups. As compared to the US
mortality rate due to hypertension, South Carolina falls in the 36.8 to 44.7 per 100,000
range, which is considerably higher as compared to other states in the US. The most
concentrated areas of mortality due to hypertension seem to be located in the southeastern
regions including considerably higher rates from Georgia, Florida, to Texas. Maps 4, 5,
and 6 display the Age Adjusted Rates for the US population for comparison to SC rates.
(CDC Wonder, 2007).
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, In SC groul!edb.y R ace
T a ble A A·I~e Ad·IJUSt ed an d C
rudeRa t es per 100000·
Race

State

White
Black! AA
Other

SC (45)
SC (45)
SC (45)

Count
1,888
1,851
4

Population
13,941,393
6,066,453
294,649

Crude Rate
per 100,000
13.5
30.5
1.4*

Age Adj usted Rate
per 100,000
13.1
41.5
1.7*

*Number may be unrehable accordmg to CDC Wonder
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Map 1: Counts by county for White Hypertensives in SC
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Map 3: Counts by county for Other Race Hypertensives in South Carolina
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Appendix C - Subset Cobort Data
Subset Study Population:
A subset of76 subjects had 25m! serum blood samples collected for a lipid profile
to measure total cholesterol, LDL, HDL, white blood cell count (WBe),
hemoglobinA1C, fibrinogen, triglyceride levels. All blood samples test were completed
by MUSe, General Clinical Research Center (GCRC).
Results:
When examining the subset of subjects with blood sample analysis age,
Hemoglobin Ale, High LDL greater than 160, HDL, Fibrinogen, and elevated fibrinogen
above 300 was significantly correlated with arterial stiffness score (p-value <0.10);
however, there was no association present with the various disease states in this subset
population. Diabetes, kidney disease, and low HDL below 40 were significantly
associated with arterial stiffness score (Table C).
Discussion:
In the subset population with lipid profiles, we found that Hemoglobin Ale, LDL
above 160, HDL, and Fibrinogen above 300 was statistically associated with Arterial
Stiffness Score, and could possibly be a another predictor of vessel disease and
atherosclerosis diagnoses. Fasting glucose has been shown to be highly associated with
arterial stiffness, proportionately with level of blood glucose, even among normal healthy
subjects. Hyperglycemia is a common factor for both Type 1 and Type 2 diabetic
individuals!! and has been shown to be associated with an increase in arterial stiffness
when compared to non-diabetic individuals, even though many other factors including
disease duration and degree of therapy control are thought to influence this affect as well
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(Lehmann, ED, et ai, 1992). In vitro studies have shown a link between arterial stiffness
and hypercholesterolemia along with clinical studies suggesting a significant positive
correlation between cholesterol and low-density lipoprotein cholesterol (LDL), and a
negative correlation with high-density lipoprotein cholesterol (HDL) with arterial
stiffness. Familial hypercholesterolemia has also been shown to be associated with the
stiffening of the arterial wall; which implies possible genetic and environmental
components may play an essential role in the development of arterial stiffness and
atherosclerosis (Cheng, HM, 2007).
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Table CO' Summary Statistics for blood samples (N=76)

Parameters
Arterial Stiffness Score (1-3)
Age
Gender (male)
Race (white)
Hypertension
Diabetes
H~ercholesterolemia
M~ocardial

Infarction

Stroke
Heart disease
Kidne~roblems

Blood clots
Overweight (BMI >25)
HbAIC
High HbAIC
Total Cholesterol
High Total Cholesterol
LDL
High LDL
HDL
LowHDL
Tri~!ycerides

High Triglycerides
Fibrinogen
Elevated Fibrinogen

Total
Population Pearson's P CHI-SQ
N=76
value
P value
45 (59%)
<.0001
57.1 ± 12.7
38 (50%)
0.1539
0.1350
0.9124
66 (87%)
0.6810
0.2271
32 (42%)
0.1114
0.0652
10 (13%)
0.2387
0.8119
31(41%)
0.3782
0.2834
6 (8%)
0.4889
0.2834
0.4889
6 (80/0J
12 (16%)
0.3051
0.1518
0.0343
8 (11%)
0.5958
3 (4%)
0.3026
0.8824
54 (710/0)
0.2573
0.4136
5.53 ± 0.67
0.0922
4 (5%)
0.2008
0.7156
0.1259
193.88 ± 42.7
0.3690
13 (17%)
0.1383
118.42 ± 37.8
0.3047
0.1815
12 (16%)
0.0673
0.0454
46.71 ± 15.6
29 (39%)
0.0737
0.1083
149.03 ± 103.2
0.3697
14 (19%)
0.7946
0.4120
354.58 ± 79.0
0.0338
62 (82%)
0.2168
0.0758

'" Data are expressed as frequencies for categorical variables and means ± standard
deviation for continuous variables~ HbAIC - Hemoglobin Ale; High HbA1C;:: 7~ High
Total Cholesterol ~ 240~ High LDL ~ 160; Low HDL < 40~ High Triglycerides ~ 200~
Elevated Fibrinogen ~ 300; Zero Smokers in Subset~oup.
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Appendix D - Health Survey
HEAL TH INTERVIEW
Study ID Number
Gender
Male
Female
CliniclLocation
Date of last periodontal exam
I
1_ _ __
What is your birth date?
I
1_ _ __
Height
Weight_ _ _ _ _ __
How would you best describe your racial identity? Circle all that apply.
White
Black
Hispanic
Asian
Other
How many times a week do you exercise?
How many times a day do you brush your teeth?
How many times a day do you use dental floss?
When was your last visit to a dentist?
Month
Y ear_~_ _
Do you have a regular dentist or dental clinic?
YES NO
Has a dentist ever told you that you have gum disease, periodontitis, or gingivitis?
YES NO
DON'T KNOW
Have you ever undergone any treatment for gum disease?
YES NO
DON'T KNOW
IF YES -:)
Treatments done
Have you smoked at least 100 cigarettes in your lifetime? YES
NO
On average, about how many cigarettes a day DOIDID you smoke?
How many years have you smoked? _ _ _ _ __
Have you used chewing tobacco or snuff, such as Redman, Beechnut, Copenhagen, or
Skoal, at least 20 times?
YES
NO
On average, about how many times a day DOIDID you use snuff or chewing tobacco?
What is the usual number of alcoholic beverages you HA VEIHAD per week?

How long ago was your last cup of coffee/tealcaffeinated beverage?
Have you ever had a HEART ATTACK?

YES

NO

DON'T KNOW

IF YES-7

How many times?
How long ago?
Have you ever had a STROKE?
YES NO
DON'T KNOW
How many times?
How long ago?
Do you use aspirin on a regular basis?
YES NO
DON'T KNOW
YES -7
How many days a week are you taking aspirin?
What dosage do you take?
mg

IF YES -7
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Has a doctor ever told you that you had any of the following:
Heart Disease
YES NO
Kidney Problems
YES NO
IF YES~List?
Rheumatic fever, faulty
heart valve, or heart murmur?
YES NO
Blood clots in the lung or
in the leg veins?
YES NO
Artificial joint replacement?
YES NO
Which joint and date of most recent surgery?
High Blood Pressure or Hypertension?
YES .NO
IF YES:
Are you taking medicine for this?
YES NO
IF YES~Names ifknown?

High Blood Cholesterol
IF YES:
Are you taking medicine for this?
IF YES-7Names ifknown?

DON'T KNOW
DON'T KNOW

DON'T KNOW
DON'T KNOW
DON'T KNOW
DON'T KNOW
DON'T KNOW

YES

NO

DON'T KNOW

YES

NO

DON'T KNOW

YES NO
DON'T KNOW
Diabetes
IF YES:
Are you taking medicine for this?
DON'T KNOW
YES NO
IF YES 7Insulin or Pills:- - - - Was insulin your frrst diabetes medicine?
YES NO
DON'T KNOW
FOR WOMEN:
Did diabetes occur only during pregnancy? YES NO
DON'T KNOW
What medications andlor supplements are you currently taking?

What is the highest degree or level of school you have completed?
No Schooling
Technical School Certificate
Grades 1-8
Associate degree (Junior College, e.g. AA, AS)
Grades 9-11
Bachelor's degree (e.g. BA, AB, BS)
Completed high school
Graduate or professional school
Some college but no degree
Are you currently employed outside the home?
YES NO
Are you retired?
YES NO
What is/was your usual occupation?
On this sheet is a list of income groups. Please circle which group best represents your
total combined family income for the past 12 months. This includes the total income
before taxes earned in the past ear by all family members living with you. Please include
money from jobs, net income from business, farm or rent, pensions, dividends, welfare,
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social security payments and any other money received by you or any other family
member living with you .
Less than 5,000
16,OOO-19~999
35,000-39,999
100,000 or more
5,000-7,999
20,000-24,999
40,000-49,999
8,000-11,999
25,000-29,999
50,000-74,999
12,000-15,999
30,000-34,999
75,000-99,999
To help pay for your medical care, do you now have: (circle all that apply)
HMO or other private insurance such as Blue Cross, Aetna, 1199 Fund, etc.
Medicare
Medicaid
Military or Veteran's Administration sponsored
None
Other: - - - - - - - Interview date

- -I- -I- -

Health Interview Survey designed by Dr Amal Rastogi.
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Appendix E - IRB Approval
This study was approved for Exempt Research/Quality Assessment Review by
Muse Institutional Review Board on 12/13/2007. HR number 17855. Expiration Date
12/13/2012.
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Map 5: Age Adjusted Rates per 100,000 for BlacklAA Hypertensives in the US
Age Adjusted Rate for The United States
Race: Black or African American
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